Context: On 2 July 2012, GlaxoSmithKline pleaded guilty to criminal charges and agreed to a $3 billion settlement of the largest health-care fraud case in the U.S. and the largest payment by a drug company. The settlement is related to the company's illegal promotion of prescription drugs, its failure to report safety data, bribing doctors, and promoting medicines for uses for which they were not licensed. The drugs involved were Paxil, Wellbutrin, Advair, Lamictal, and Zofran for off-label, non-covered uses. Those and the drugs Imitrex, Lotronex, Flovent, and Valtrex were involved in the kickback scheme.

Question: How much was the settlement GlaxoSmithKline agree to?
Answer: $3 billion

Question: What was one of the causes of the health-care fraud case?
Answer: illegal promotion of prescription drugs

Question: When did GlaxoSmithKline plead guilty?
Answer: 2 July 2012

Question: What drugs were related to a kickback scheme?
Answer: Imitrex, Lotronex, Flovent, and Valtrex

Question: What drugs were used for off-label uses?
Answer: Paxil, Wellbutrin, Advair, Lamictal, and Zofran

Question: In what year did GlaxoSmithKline pay a $3 billion dollar settlement?
Answer: 2012

Question: How much was the largest healthcare fraud case in the US settled for?
Answer: $3 billion

Question: What company was sued for promoting medicines for unlicensed uses and bribing doctors?
Answer: GlaxoSmithKline

Question: How much was the settlement Wellbutrin agreed to?
Answer: Unanswerable

Question: What was one of the causes of the Wellbutrin case?
Answer: Unanswerable

Question: When did Wellbutrin plead guilty?
Answer: Unanswerable

Question: What drugs were related to Advair's scheme?
Answer: Unanswerable

Question: What drugs were used for label uses?
Answer: Unanswerable